Chemoinformaics analysis of Nerol-6-O-Alpha-L-Rhamnopyranosyl-Beta-D-Glucopyranoside
| Molecular Weight | 462.536 | nRot | 9 |
| Heavy Atom Molecular Weight | 424.232 | nRig | 14 |
| Exact Molecular Weight | 462.246 | nRing | 2 |
| Solubility: LogS | -2.185 | nHRing | 2 |
| Solubility: LogP | 0.655 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 70.0981 |
| nHD | 6 | BPOL | 45.0659 |
| QED | 0.243 |
| Synth | 4.637 |
| Natural Product Likeliness | 2.255 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.863 |
| Pgp-sub | 0.805 |
| HIA | 0.96 |
| CACO-2 | -5.345 |
| MDCK | 0.000168865 |
| BBB | 0.22 |
| PPB | 0.59983 |
| VDSS | 0.472 |
| FU | 0.246522 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.048 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.128 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.206 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.014 |
| CL | 1.284 |
| T12 | 0.235 |
| hERG | 0.015 |
| Ames | 0.258 |
| ROA | 0.047 |
| SkinSen | 0.028 |
| Carcinogencity | 0.115 |
| EI | 0.008 |
| Respiratory | 0.021 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.84653 |